Definitive Contract HHSN268200682279C
Award Date 9/30/06
Potential Completion Date 8/21/13
Potential Value $2.4M
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The University of Texas M.D. Anderson Cancer Center (MD Anderson) to provide additional funding for a previously awarded contract, 263-MJ-611300. The contract is a firm-fixed-price purchase order with a ceiling value of $100,000.00 and an ultimate completion date of September 30, 2008. The contract does not have a set-aside designation. MD Anderson...
- This is a federal contract award from the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to The University of Texas MD Anderson Cancer Center, a state-run hospital and research institution in Houston, Texas. The $8,039,555.77 definitive cost-reimbursement contract supports the Salivary Gland Tumor Biorepository (SGTB) program, which is focused on biomedical research related to salivary gland tumors. The contract has an ultimate completion date of...
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract, valued at $20,094,324.00, is for the provision of cancer information services. The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of January 14, 2010. MD Anderson, a comprehensive cancer treatment and research center, has received...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- This is a modification to a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The original contract was a definitive cost-no-fee contract awarded on February 15, 2003 with a ceiling value of $8,606,292. This modification is to deobligate FY06 funds. MD Anderson, a U.S. state government entity and academic medical center, has been the prime contractor as...
- This federal contract was awarded by the Department of Health and Human Services' Food and Drug Administration to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $283,546.12, is for a study titled "Modular Application of Surface Technology for the Generation of Antigen-Specific T Cells." It is a definitive contract with a cost-no-fee pricing type, awarded on September 13, 2019 with a completion date of...
- This federal contract award was made by the National Aeronautics and Space Administration (NASA) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct research on "Molecular Lesions in Dendritic Cells Cultivated in Modeled Microgravity." The $660,000.00 grant-funded research project ran from December 1, 2003 to September 30, 2008. The award was not set aside for any specific business category. MD Anderson is a comprehensive...
- This is an indefinite delivery contract (IDC) awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson) for $1,967,472.00 to provide support services for medical radiation dosimetry for epidemiology studies. The contract does not have a set-aside designation. MD Anderson, a comprehensive cancer treatment and research center that is part of the University of Texas System, has extensive...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract, valued at $728,679.40, is for research to support the "Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH)". The contract is part of the National Cancer Institute's...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in the amount of $400,411.43. The contract was issued under the PREVENT Cancer Program (PREVENT) contract vehicle and supports the PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS project with a period of performance through...